This study was designed to evaluate the potential benefits of treatment with biventricular device in patients with normal systolic function , indication for pacing and impaired atrio-ventricular conduction , by comparing the treatment with dual-chamber device . The REAL -CRT study is designed to test the hypothesis that, in patients with atrioventricular block of I degree and standard pacing indications , biventricular pacing is superior to single stimulation of the right ventricle (RV) with optimized algorithms for minimization of pacing , as assessed by echocardiography an endpoint defined in terms of maintenance over time of left ventricular ejection fraction (LVEF ) and left ventricular end-systolic volume ( LVESV ) .
Clinical data suggest that biventricular pacing is able to preserve the myocardial performance more effectively than the right ventricular pacing in patients with atrioventricular block and mild systolic dysfunction . In particular, some studies have shown that medical therapy in these patients could be responsible for an increase in the cumulative percentage of chronic pacing over the 40% threshold , the threshold associated with a higher incidence of atrial fibrillation and hospitalization for heart failure and ventricular arrhythmias . In addition , patients with pre-existing left ventricular dysfunction and indication for pacing standards have improved left ventricular systolic function , exercise capacity and quality of life as a result of biventricular pacing as compared with Right ventricular pacing . These results suggest that biventricular pacing is a feasible option for permanent pacing in patients who have normal systolic function of the left ventricle and that this can be altered from the adverse effects of conventional Right ventricular pacing on systolic function of the left ventricle . This reality has prompted physicians to assess the value and role of cardiac resynchronization therapy (CRT ) in patients with prolonged Atrio-Ventricular (AV) conduction . Note the deleterious effects of chronic stimulation of the right ventricle , the optimal pacing mode should always be considered in these patients at the time of implantation . This study was designed to evaluate the potential benefits of treatment with biventricular device in patients with normal systolic function , indication for pacing and impaired atrio-ventricular conduction, by comparing it with the treatment with dual chamber device
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
164
biventricular stimulation with cardiac resynchronization therapy pacemaker (crt-p)
right ventricular stimulation with dual chamber pacemaker
Azienda Ospedaliera Sant'Anna
Como, Como, Italy
RECRUITINGLVEF
LVEF (Left Ventricular Ejection Fraction: such as the assessment of systolic function of the left ventricle)
Time frame: 2 years
LVESV
LVESV (Left Ventricular End Systolic Volume: such as the assessment of left ventricular remodeling)
Time frame: 2 years
echocardiographic left ventricular measures
. Structure and cardiac function: * Left ventricular End Systolic Diameter, Left ventricular End Diastolic Diameter * Left Ventricular End Systolic
Time frame: 2 years
Echocardiographic altrial measures
Size of the left atrium (diameter and volume)
Time frame: 2 years
Clinical outcome
Clinical benefit: * 6 minute walking test * quality of life questionnaire * New York Heart Association class * number and duration of hospitalizations
Time frame: 2 years
Atrial fibrillation (AF)
Incidence of AF: * incidence of persistent AF * burden of FA * new onset of AF
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.